Insights On Trial Design
-
Cognitive, Pharmacodynamic Testing During FIH CNS Trials
5/22/2024
A comprehensive review of optimal timing and methodologies for cognitive and pharmacodynamic testing during first-in-human trials on CNS-active compounds.
-
Site Networks And Hybrid Solutions
7/22/2025
Learn how community- and patient-centric site networks that have DCT capabilities are able to work with a broad-range of site types.
-
Gastric Cancer - Global Clinical Trial Landscape (2024)
9/17/2024
Discover the latest in gastric cancer research with this detailed report, highlighting new therapies, clinical trials, and future innovations.
-
At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense
12/23/2025
At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.
-
Faster Trial Planning and Site Selection
4/15/2025
Address the challenges of identifying the most suitable trial sites and investigators while optimizing feasibility planning, reducing screen failure rates, and improving patient retention.
-
EHR-To-EDC Success In A Complex, Adaptive Platform Trial
4/17/2025
I-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.
-
Antibody-Drug Conjugates Clinical Trials 2024
6/3/2024
Gain comprehensive insights into Antibody-Drug Conjugates (ADCs) with our 2024 clinical trial report, offering a deep dive into new drug developments and market trends shaping cancer treatment.
-
The Win-Win Wth Virtual Visits – Better Experiences, Better Data
2/29/2024
Discover how researchers can design studies with the needs of the patient in mind to promote faster enrollment, high engagement, and the production of more complete and accurate data.
-
Accelerating Early Phase Oncology Study Development
4/17/2025
Explore a close collaboration to co-develop a comprehensive, adaptive protocol designed to support key decisions across multiple trial phases for an innovative cancer therapy.
-
Why Is Clinical Trial Patient Travel So Important?
4/28/2025
Removing travel barriers in clinical trials ensures broader access, diverse participation and stronger results, benefiting both patients and researchers alike.